Antiviral Morinda citrifolia L. based formulations and methods of administration

A formulation for inhibiting at least one aspartic peptidase comprising:

• processed Morinda citrifolia fruit juice in an amount by weight between about 0.1-80%;
• processed Morinda citrifolia oil present in an amount by weight between about 0.1-20%;
• and
• a carrier medium present in an amount by weight between about 20-90 percent, wherein the formulation is formulated to include quercetin in an amount between about 0.01 and 10% by weight such that the formulation inhibits at least one aspartic peptidase when ingested by a human.